Stocktwits on MSN
Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study
The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback